A new drug development company to focus on microbiome-based, oral delivery of immunological therapies.Read More
Virtici Announces a New Spin-Out, Rise Therapeutics, Focused on Microbiome Platform Technologies for the Development of Immunological-Based Therapies
A new drug development company to focus on microbiome-based, oral delivery of immunological therapies.
Grünenthal, Celdara Medical, Virtici, and MBV Announce Strategic Partnership to Develop Pain Management Drugs
A partnership to accelerate early stage innovations focused on pain management to bolster Grünenthal’s product pipeline.
A collaborative network of affiliates to improve human health by developing the highest potential innovations.